Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Randomized Study of PARP Inhibitor Maintenance Regimens in High-Risk Advanced Ovarian Cancer
jRCT1041260072Phase 2Not yet recruiting
- Start
- Jun 2026
- Countries
- 1
01
Overview
Phase 2, randomised trial in ovarian cancer (2 arms). Planned start Jun 2026; status: not yet recruiting.
02
Conditions
ovarian cancer
Beyond the preview
Go deeper on jRCT1041260072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041260072.